XML 82 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (10,087,000) $ (15,762,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 2,145,000 1,692,000
Issuance of common stock for bonus 870,000
Stock based payments for professional services rendered 190,000
Stock based payments for employees and directors 5,000
(Loss)/gain on equity method investment 4,000 (3,000)
Loss (gain) on investments (1,255,000) 1,021,000
Change in ROU assets 484,000 556,000
Change in inventory obsolescence (49,000)
Accrued interest on notes payable 1,408,000 3,292,000
Loss on sale of assets 727,000 (165,000)
Impairment of intangibles 600,000
Impairment of accounts receivable 599,000
Provision for loan losses 20,000 1,627,000
Gain on extinguishment of debt (595,000)
Decrease (increase) in assets:    
Accounts receivable (1,670,000) 1,557,000
Inventory (380,000) (488,000)
Assets held for sale (38,000)
Prepaid expenses and other current assets 381,000 (80,000)
Other assets (1,113,000) (36,000)
Increase (decrease) in liabilities:    
Accounts payable 315,000 (255,000)
Accrued expenses 326,000 (111,000)
ROU liabilities (463,000) (511,000)
Other liabilities 1,777,000
Net cash used by operating activities (7,576,000) (5,889,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (226,000) (29,000)
Sale of real estate 9,023,000
Purchase of marketable securities (2,794,000)
Purchase of investment (1,861,000)
Disposal of property, plant and equipment 5,140,000
Sale of investment, related party 2,414,000
Sale of marketable securities 3,438,000 3,029,000
Issuance of new notes receivable, net origination fees (402,000)
Payments received on notes receivable 225,000 4,039,000
Net cash provided by investing activities 12,080,000 9,916,000
Cash flows from financing activities:    
Payments of long-term debt (11,492,000) (1,492,000)
Borrowings of long-term debt, net 3,250,000 254,000
Debt issuance costs (131,000)
Borrowings of convertible note payable - related party 500,000
Payments on margin loan (943,000)
Issuances of common stock, net of issuance costs 2,227,000
Net cash provided (used) by financing activities (8,816,000) 989,000
Net increase (decrease) in cash (4,312,000) 5,016,000
Cash and cash equivalents at beginning of period 11,431,000 6,615,000
Cash and cash equivalents and restricted cash at end of period 7,119,000 11,631,000
Cash and cash equivalents 7,019,000 11,631,000
Restricted cash $ 100,000